| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c55cf09075f2848a0dfae645dc51ec76 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 |
| filingDate |
2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f142c7b04ed4901b91e80696c3102ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2722231eeda194123f8778e75ecd1d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0721d2bb1f404845bc64249626f85c |
| publicationDate |
2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-102019000725-A2 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION UNDERSTANDING SILVER SADPHIAZIN 1% (10 MG / G) AND DEXPANTENOL 5% (50MG / G) IN DERMATOLOGICAL CREAM FOR BURN TREATMENT AND ITS OBTAINING PROCESS |
| abstract |
The present pharmacotechnical development relates to a dermatological cream composition containing 1% silver sulfadiazine (10 mg / g) and 5% dexpanthenol (50 mg / g), indicated for treating 1st, 2nd and 3rd degree burns as well as as wounds that are difficult to reepithelize. |
| priorityDate |
2019-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |